Does EPOPROSTENOL Cause Central venous catheterisation? 361 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 361 reports of Central venous catheterisation have been filed in association with EPOPROSTENOL (EPOPROSTENOL). This represents 2.7% of all adverse event reports for EPOPROSTENOL.
361
Reports of Central venous catheterisation with EPOPROSTENOL
2.7%
of all EPOPROSTENOL reports
39
Deaths
305
Hospitalizations
How Dangerous Is Central venous catheterisation From EPOPROSTENOL?
Of the 361 reports, 39 (10.8%) resulted in death, 305 (84.5%) required hospitalization, and 10 (2.8%) were considered life-threatening.
Is Central venous catheterisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EPOPROSTENOL. However, 361 reports have been filed with the FAERS database.
What Other Side Effects Does EPOPROSTENOL Cause?
Dyspnoea (2,744)
Headache (2,425)
Diarrhoea (2,310)
Nausea (2,016)
Pain in jaw (1,928)
Death (1,362)
Flushing (1,256)
Fatigue (1,133)
Hospitalisation (1,078)
Vomiting (1,068)
What Other Drugs Cause Central venous catheterisation?
AMBRISENTAN (263)
TREPROSTINIL (208)
ECULIZUMAB (105)
VENETOCLAX (89)
MACITENTAN (78)
PEMBROLIZUMAB (70)
AZTREONAM LYSINE (63)
ADALIMUMAB (59)
NATALIZUMAB (57)
GLYCINE\MANNITOL\SODIUM (56)
Which EPOPROSTENOL Alternatives Have Lower Central venous catheterisation Risk?
EPOPROSTENOL vs EPTIFIBATIDE
EPOPROSTENOL vs EPTINEZUMAB-JJMR
EPOPROSTENOL vs EPTINEZUMAB\EPTINEZUMAB-JJMR
EPOPROSTENOL vs EQUINE BOTULINUM NEUROTOXIN A/B/C/D/E/F/G IMMUNE FAB2
EPOPROSTENOL vs EQUINE THYMOCYTE IMMUNE GLOBULIN